MedTrace Logo

COVID-19 Infection and Idiopathic Membranous Nephropathy

NCT05691179 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 130

Last updated 2023-02-14

No results posted yet for this study

Summary

Infection is one of common risk factors for relapsing of idiopathic membranous nephropathy (IMN). However, it is still unclear wheather COVID-19 infection can induce the relapsing of IMN. Herein, in this prospective, multi-center, cohort study, the investigator enrolled the IMN patients with COVID-19 infection.

All subjects will be followed for three months with four visits at 1, 2 and 3 months. Then the investigator will compare the rate of replase of IMN in the two groups to evaluate the association of COVID-19 infection and replapse of IMN.

Conditions

  • Idiopathic Membranous Nephropathy

Sponsors & Collaborators

  • Beijing Pinggu District Hospital

    collaborator OTHER

  • Beijing Fangshan District Liangxiang Hospital

    collaborator OTHER

  • Beijing Friendship Hospital

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-12-10
Primary Completion
2023-05-31
Completion
2023-05-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05691179 on ClinicalTrials.gov